Oxford Biomedica | Sustainability Performance
Oxford Biomedica plc develops and manufactures gene and cell therapy products. The company focuses on offering contract development and production services for biotechnology and pharmaceutical clients.
1995
United Kingdom
501 - 1,000 employees
Biotechnology
$100M - 500M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#1946
Overallⓘ#205
in United Kingdomⓘ#29
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon certificatesGovernance
TargetsFinancial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Oxford Biomedica's lentiviral vector manufacturing for gene therapies carries inherent biosafety considerations requiring stringent containment.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
4-6
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.